TY - JOUR
AU - H. Pham
AU - C. Lin
AU - D. B. Nguyen
AU - L. J. Mooney
AU - G. M. Le
AU - S. J. Shoptaw
AU - H. Van Truong
AU - Y. I. Hser
A1 - 
AB - Untreated co-occurring mental health disorders (MHD) and substance use disorders (SUD) are associated with negative treatment outcomes. This study explored the experiences and perspectives of patients with opioid use disorder (OUD) who were using methamphetamine while undergoing methadone maintenance treatment (MMT) regarding barriers and facilitators to accessing MHD services. We conducted 30 in-depth interviews with MMT participants with varying levels of MHD severity, assessed using the 21-item Depression, Anxiety, Stress Scale (DASS-21). Barriers to seeking MHD services included lack of awareness, fear of additional stigma and extra burden to families, unaddressed poly-substance use, and lack of specialized professionals. Benefits of integrating MHD services into MMT clinics included improved diagnosis, streamlined referrals, and reduced logistical challenges. Key facilitators identified included supportive family members, healthcare professionals, and digital platforms. Integrating MHD care into MMT, emphasizing family involvement, staff training, and digital platforms, holds promise to improve MHD diagnosis, referral, and treatment.
AD - Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, USA.; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.; VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.; Department of Family Medicine, University of California, Los Angeles, CA 90024, USA.
AN - 41551419
BT - Int J Ment Health Addict
C5 - Opioids & Substance Use
DA - Dec 19
DO - 10.1007/s11469-025-01616-w
DP - NLM
ET - 20251219
JF - Int J Ment Health Addict
LA - eng
N2 - Untreated co-occurring mental health disorders (MHD) and substance use disorders (SUD) are associated with negative treatment outcomes. This study explored the experiences and perspectives of patients with opioid use disorder (OUD) who were using methamphetamine while undergoing methadone maintenance treatment (MMT) regarding barriers and facilitators to accessing MHD services. We conducted 30 in-depth interviews with MMT participants with varying levels of MHD severity, assessed using the 21-item Depression, Anxiety, Stress Scale (DASS-21). Barriers to seeking MHD services included lack of awareness, fear of additional stigma and extra burden to families, unaddressed poly-substance use, and lack of specialized professionals. Benefits of integrating MHD services into MMT clinics included improved diagnosis, streamlined referrals, and reduced logistical challenges. Key facilitators identified included supportive family members, healthcare professionals, and digital platforms. Integrating MHD care into MMT, emphasizing family involvement, staff training, and digital platforms, holds promise to improve MHD diagnosis, referral, and treatment.
PY - 2025
SN - 1557-1874 (Print); 1557-1874
ST - Mental Health Care for Patients with Opioid Use Disorder and Methamphetamine Use in Methadone Maintenance Treatment: Experiences and Perspectives
T1 - Mental Health Care for Patients with Opioid Use Disorder and Methamphetamine Use in Methadone Maintenance Treatment: Experiences and Perspectives
T2 - Int J Ment Health Addict
TI - Mental Health Care for Patients with Opioid Use Disorder and Methamphetamine Use in Methadone Maintenance Treatment: Experiences and Perspectives
U1 - Opioids & Substance Use
U3 - 10.1007/s11469-025-01616-w
VO - 1557-1874 (Print); 1557-1874
Y1 - 2025
ER -